Adial Pharmaceuticals Inc.

06/29/2022 | Press release | Distributed by Public on 06/30/2022 04:06

Notice of Effectiveness (Form EFFECT)

Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 29, 2022
Accession Number: 0001213900-22-034938
Submission Type: POS AM
CIK: 0001513525
Company Name: ADIAL PHARMACEUTICALS, INC.
File Number: 333-220368